RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MXCT.L
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

MaxCyte Inc. stock price ended at £309.00 on Tuesday, after losing 3.44%.
(Updated on Jul 02, 2024)

Sell candidate since Jul 01, 2024 Loss -3.44% PDF

The MaxCyte Inc. stock price fell by -3.44% on the last day (Tuesday, 2nd Jul 2024) from £320.00 to £309.00. During the last trading day the stock fluctuated 1.61% from a day low at £304.10 to a day high of £309.00. The price has fallen in 6 of the last 10 days and is down by -15.85% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -5 thousand shares and in total, 3 thousand shares were bought and sold for approximately £1.07 million.

Given the current short-term trend, the stock is expected to rise 10.62% during the next 3 months and, with a 90% probability hold a price between £341.83 and £441.87 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MXCT.L Signals & Forecast

There are few to no technical positive signals at the moment. The MaxCyte Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at £321.29 and £357.18. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 11, 2024, and so far it has fallen -20.77%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for MaxCyte Inc. stock

MaxCyte Inc. finds support from accumulated volume at £297.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved £4.90 between high and low, or 1.61%. For the last week the stock has had daily average volatility of 1.49%.

MaxCyte Inc. is oversold on RSI14 (14). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MXCT.L) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect MaxCyte Inc. to open at £307.37, and during the day (based on 14 day Average True Range), to move between £294.42 and £323.58, which gives a possible trading interval of +/-£14.58 (+/-4.72%) up or down from last closing price. If MaxCyte Inc. takes out the full calculated possible swing range there will be an estimated 9.44% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at £297.00 (3.88%) than the resistance at £330.00 (6.80%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is MaxCyte Inc. stock A Buy?

The MaxCyte Inc. stock holds several negative signals and despite the positive trend, we believe MaxCyte Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.236 Sell Candidate Unchanged

Predicted Opening Price for MaxCyte Inc. of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
£307.37 ( 0.529%) £309.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MXCT.L

Fibonacci Support & Resistance Levels

Level Price
R3 312.27 1.06%
R2 310.39 0.451%
R1 309.24 0.0772%
Price 309.00
S1 305.49 -1.13%
S2 304.34 -1.51%
S3 302.47 -2.11%

Accumulated Volume Support & Resistance Levels

Level Price
R3 375.00 21.36%
R2 370.00 19.74%
R1 330.00 6.80%
Price 309.00
S1 297.00 -3.88%
S2 295.00 -4.53%
S3 290.00 -6.15%

FAQ

What is the symbol for MaxCyte Inc. Stock and on which exchange is it traded?
The symbol for MaxCyte Inc. is MXCT.L and it is traded on the XLON (London Stock Exchange).

Should I buy or sell MaxCyte Inc. Stock?
The MaxCyte Inc. stock holds several negative signals and despite the positive trend, we believe MaxCyte Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy MaxCyte Inc. Stock?
MaxCyte Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy MaxCyte Inc. Stock.

What's the current price of MaxCyte Inc. Stock?
As of the end of day on the Jul 02, 2024, the price of an MaxCyte Inc. (MXCT.L) share was £309.00.

What is the 52-week high and low for MaxCyte Inc. Stock?
The 52-week high for MaxCyte Inc. Stock is £430.00 and the 52-week low is £205.00.

What is the market capitalization of MaxCyte Inc. Stock?
As of the Jul 02, 2024, the market capitalization of MaxCyte Inc. is 323.041M.

When is the next earnings date for MaxCyte Inc.?
The upcoming earnings date for MaxCyte Inc. is Aug 07, 2024.
Click to get the best stock tips daily for free!

About MaxCyte Inc.

MaxCyte. MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale... MXCT.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT